Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.00620-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Tina I Bui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Antibodies, Sensitivity and Specificity, Point-of-Care Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Many emergency departments (ED) use rapid human immunodeficiency virus (HIV) antibody tests as screening tools, despite limited sensitivity for detecting acute HIV infections. In a 4-year retrospective analysis of 1,192 patients, we evaluated the performance of a third-generation rapid HIV antibody assay tested at point-of-care (POC, Chembio Sure Check HIV 1/2) against in-lab fourth-generation screening (Abbott Architect Ag/Ab Combo). Compared to complete algorithmic testing, the POC test demonstrated a 92.5% sensitivity (95% CI = 84.6–96.5), 98.1% specificity (95% CI = 97.1–98.8), 99.5% negative predictive value (NPV; 95% CI = 98.8–99.8), and a 77.9% positive predictive value (PPV; 95% CI = 68.6–85.1). Notably, the POC test failed to detect 100% (3/3) of acute HIV infections (defined as Fiebig stage 2) and 3.8% (2/52) established HIV infections, where viral loads were 5.9, 6.7, and >7 log 10 copies/mL. Symptoms such as fever, nausea/vomiting, malaise, headache, and photophobia were significantly associated with acute HIV infections diagnosed in the ED. The rapid HIV antibody test demonstrated high sensitivity, specificity, and NPV in our study population, reaffirming its effectiveness as a valuable screening tool. However, the low PPV and 100% failure to detect acute HIV infections underscore the importance of prioritizing in-lab fourth-generation HIV antigen/antibody combination immunoassays in cases of suspected acute HIV infection to ensure a timely and accurate diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA.
- Department of Pathology, University Hospitals Health System, Cleveland, Ohio, USA.
ORCID-Profile: Tina I Bui, Christopher W Farnsworth, Neil W Anderson
Zitieren
APA
Bui, T. I., Farnsworth, C. W., & Anderson, N. W. (2024). Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00620-24
Vancouver
Bui TI, Farnsworth CW, Anderson NW. Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00620-24
BibTeX
@article{Bui2024,
author = {Bui, Tina I and Farnsworth, Christopher W and Anderson, Neil W},
title = {Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.00620-24}
}
EUVIMED